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Helen M. Rodgers,1,2,3 Marycharmain Belcastro,1,4 Maxim Sokolov,1,4,5 Peter H. Mathers1,3,4,5
Sensory Neuroscience Research Center, West Virginia University School of Medicine, Morgantown, WV; 2Neuroscience Graduate
Program, West Virginia University School of Medicine, Morgantown, WV; 3Department of Otolaryngology, West Virginia
University School of Medicine, Morgantown, WV; 4Department of Ophthalmology, West Virginia University School of Medicine,
Morgantown, WV; 5Department of Biochemistry, West Virginia University School of Medicine, Morgantown, WV
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Purpose: Photoreceptor cells are born in two distinct phases of vertebrate retinogenesis. In the mouse retina, cones
are born primarily during embryogenesis, while rod formation occurs later in embryogenesis and early postnatal ages.
Despite this dichotomy in photoreceptor birthdates, the visual pigments and phototransduction machinery are not reactive to visual stimulus in either type of photoreceptor cell until the second postnatal week. Several markers of early
cone formation have been identified, including Otx2, Crx, Blimp1, NeuroD, Trβ2, Rorβ, and Rxrγ, and all are thought
to be involved in cellular determination. However, little is known about the expression of proteins involved in cone
visual transduction during early retinogenesis. Therefore, we sought to characterize visual transduction proteins that
are expressed specifically in photoreceptors during mouse embryogenesis.
Methods: Eye tissue was collected from control and phosducin-null mice at embryonic and early postnatal ages. Immunohistochemistry and quantitative reverse transcriptase-PCR (qPCR) were used to measure the spatial and temporal
expression patterns of phosducin (Pdc) and cone transducin γ (Gngt2) proteins and transcripts in the embryonic and
early postnatal mouse retina.
Results: We identified the embryonic expression of phosducin (Pdc) and cone transducin γ (Gngt2) that coincides temporally and spatially with the earliest stages of cone histogenesis. Using immunohistochemistry, the phosducin protein
was first detected in the retina at embryonic day (E)12.5, and cone transducin γ was observed at E13.5. The phosducin and
cone transducin γ proteins were seen only in the outer neuroblastic layer, consistent with their expression in photoreceptors. At the embryonic ages, phosducin was coexpressed with Rxrγ, a known cone marker, and with Otx2, a marker of
photoreceptors. Pdc and Gngt2 mRNAs were detected as early as E10.5 with qPCR, although at low levels.
Conclusions: Visual transduction proteins are expressed at the earliest stages in developing cones, well before the onset
of opsin gene expression. Given the delay in opsin expression in rods and cones, we speculate on the embryonic function
of these G-protein signaling components beyond their roles in the visual transduction cascade.

Over the past two decades, components of the vertebrate
visual transduction cascade have been characterized, and
their functions in light-regulated signaling are well established. Visual signaling in the mouse retina does not begin
until postnatal day (P) 13–14 [1]. Correspondingly, the onset
of expression for rhodopsin and the cone opsins precedes
eye opening and visual signaling by several days. However,
rod and cone histogenesis begins even earlier, occurring in
two distinct phases in vertebrate retinogenesis, with cones
born embryonically and rods formed primarily during late
embryogenesis and the postnatal period in rodents [2,3].
One of the mysteries of vertebrate retinogenesis is the
lag between cone histogenesis and cone opsin expression. A
similar lag exists between rod histogenesis and rhodopsin
expression, although the delay is not as extended and occurs
postnatally [4]. In mouse cone development, the earliest cones
Correspondence to: Peter H. Mathers, PO Box 9303, Sensory
Neuroscience Research Center West Virginia University,
Morgantown, WV 26506-9303; Phone: (304) 293 0271; FAX: (304)
293-7182; email: pmathers@hsc.wvu.edu

become postmitotic around embryonic day (E)11.5 while
cone opsin transcription starts days later, with S-cone opsin
mRNA expressed by E15.5 [5,6] followed by faint mRNA
expression for M-cone opsin around P7 [6,7]. Cone histogenesis and cone opsin protein expression shows an even greater
lag, with S-cone opsin protein expression detected at P0 [5],
and M-cone opsin protein expression detected around P14
[8,9].
Several genes involved in photoreceptor fate specification and differentiation are expressed during early cone
histogenesis, including Otx2, NeuroD, Blimp1, Rorβ, and Crx
[10-17], but these factors are all expressed in rods and cones.
Early determinants of cone differentiation include Rxrγ and
Trβ2, although again these factors are thought to regulate
cone cell fate [5,18-20]. Alternatively, proteins involved in
visual transduction (potential markers of differentiated cones)
are expressed at or slightly preceding the onset of cone opsin
expression, which is still days before the onset of visual
transduction. However, one cone marker involved in visual
transduction is expressed embryonically; cone transducin γ
expression was detected at E15.5 in mice [21].
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Transducin is a heterotrimeric G protein found in rod
and cone photoreceptors. Transducin is composed of three
subunits, designated as Gαt1β1γ1 and Gαt2β3γ8 in rods and
cones, respectively. The genes encoding the transducin
subunits in cones are Gnat2, Gnbt2, and Gngt2. Transducin
is an essential component of the phototransduction cascade.
When photons are absorbed by either rhodopsin or cone opsin,
transducin is activated. Once activated, transducin separates
into α- and βγ-subunits. The α-subunit subsequently activates
phosphodiesterase 6, which, in turn, reduces the intracellular
cGMP levels and leads to hyperpolarization. The βγ-subunit
forms a complex with phosducin, a cytosolic phosphoprotein
expressed in rods and cones [22-27]. Phosducin is involved
in the translocation of transducin βγ within photoreceptors
during light adaptation [28].
We sought to characterize the expression of visual transduction proteins that are active embryonically during cone
histogenesis. We report that phosducin and cone transducin
γ are expressed early in cone histogenesis, with phosducin
expression detected at E12.5 and cone transducin γ at
E13.5. Here, we show the spatial and temporal profiles for
the expression of these two genes and their corresponding
proteins during the embryonic and postnatal periods.
METHODS
Animals and tissue collection: Embryonic and postnatal
eyes were collected from time-pregnant FVB/N female mice
that had been mated with C57Bl/6J male mice to prevent the
retinal degeneration (rd1/rd1) present in the FVB/N strain
[29-31]. Eyes from mice at the selected ages (E13.5 and P0)
were also collected from pure C57Bl/6J mice (to test for strain
differences) and from a phosducin-null strain [28] (to test for
antibody and primer specificity). Midnight of the mating
date was considered embryonic day (E)0. The day of birth
was counted as postnatal day (P)0. For mouse pups E10.5E17.5, the mother was euthanized by cervical dislocation,
fetuses were then surgically dissected from the uterus and
decapitated. Newborn mouse pups (P0) were euthanized via
decapitation following induced hypothermia and P21 pups
were euthanized by cervical dislocation followed by decapitation. Following euthanasia, whole eyes were removed from
the orbit using either a 26g beveled needle (E10.5–E13.5) or
forceps (E15.5–P21). Eyes for immunohistology were fixed
as whole heads (E10.5–17.5) or just eyes (P0–P21) in a 4%
paraformaldehyde solution of phosphate-buffered saline (1X
PBS; 150 mM NaCl, 1.06 mM KH2PO4, 2.97 mM Na2HPO47H2O, pH 7.4) at 4 °C overnight, and cryoprotected in 30%
sucrose, 1X PBS. The eyes for the quantitative reverse
transcriptase–PCR (qPCR) analysis were frozen on dry ice
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in pairs. All animal procedures were approved by the West
Virginia University (WVU) Institutional Animal Care and
Use Committee and followed the guidelines set out by the
Association for Research in Vision and Ophthalmology.
Immunohistochemistry and immunofluorescence: Cryoprotected eyes (n = 6 for each age) were mounted in TBS tissue
freezing media (Triangle Biomedical Sciences, Durham, NC),
frozen and sectioned on a Leica CM3050S cryostat (Buffalo
Grove, IL) at 10 μm thickness, and then transferred to glass
slides. Before the antibody processing, as part of our standard
protocol, the samples were subjected to an antigen retrieval
procedure of 0.1 M Tris pH 9.5 incubation at 95 °C for 20 min.
Test runs with and without antigen retrieval showed similar
labeling for the phosducin and cone transducin γ antibodies.
Following antigen retrieval, the sections were blocked with
normal serum and treated with primary and secondary antibodies, following our published procedure [32]. The primary
antibodies used in this study were anti-phosducin (as previously described by Sokolov et al. [28]; 1:1,000), anti-cone
transducin γ (rabbit; CytoSignal, Irvine, CA; 1:500–1,000),
anti-S cone opsin (rabbit; Chemicon, Temecula, CA; 1:100),
anti-mouse cone arrestin (mouse; gift from Dr. Cheryl Craft;
1:500), anti-retinoid X receptor γ (rabbit; Santa Cruz Biotechnology, Dallas, TX; 1:1000), anti-cone phosphodiesterase
(rabbit; Thermo Fisher Scientific, Waltham, MA; 1:500),
and anti-Otx2 (rabbit; Millipore, Billerica, MA; 1:1000).
Secondary antibodies were anti-sheep, anti-mouse, or antirabbit antibodies that were either biotin-labeled for EliteABC reactions (Vector Laboratories Inc.; Burlingame, CA)
or fluorophore-tagged for immunofluorescence (Molecular
Probes, Eugene, OR). Images were captured on an Olympus
AX70 microscope (Olympus; Center Valley, PA) equipped
with a MicroFire digital camera (Optronics; Goleta, CA) or a
Zeiss 710 confocal microscope (Carl Zeiss, Inc.; Thornwood,
NY).
Quantification of colabeled cells: Eyes from E13.5, E15.5,
E17.5, and P0 mouse pups were sectioned at 12 μm thickness. Immunofluorescence following the above protocol was
performed on the retinal sections using anti-phosducin and
anti-cone transducin γ antibodies and propidium iodide as a
nuclear counterstain. Three animals per age, with multiple
quadrants of at least three sections per animal, were imaged
on a Zeiss 710 confocal microscope. Labeled cells were
counted within the imaged Z-stacks using the cell counter
plugin of Fiji imaging software (Madison, WI) [33]. All
labeled cells were counted and designated as colabeled,
phosducin only, or cone transducin γ only. The percentage
of labeled cells was then calculated by dividing the number
of cells in each category by the total number of labeled cells
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for each age. Data are presented as percentage ± standard
deviation (SD) for each category.
Quantitative reverse transcriptase–PCR: Total RNA was
isolated from pairs of eyes from three mice at each age
according to the manufacturer’s instructions using either
the Absolutely RNA Miniprep kit (Agilent Technologies,
Inc.; Santa Clara, CA) with modifications for small samples
for E13.5–P8 or the Absolutely RNA Nanoprep kit (Agilent
Technologies) for E10.5–12.5. Each RNA sample was double
DNase-treated, and the RNA concentration was quantified
with a Nanodrop ND-1000 spectrophotometer (Thermo
Scientific; West Palm Beach, FL). Select RNA samples were
also analyzed on Bioanalyzer chips (Agilent Technologies).
Fifty nanograms of total RNA were reverse transcribed
using oligo(dT) primers and the AffinityScript QPCR cDNA
Synthesis kit (Agilent Technologies), and cDNA samples
originating from the same animals were pooled. Primers were
designed using GenBank mouse mRNA sequences so that the
amplimer would cover an exon–exon boundary. The following
primer sequences were synthesized and high-performance
liquid chromatography (HPLC)–purified by Integrated DNA
Technologies (IDT; Coralville, IA); phosducin (Pdc; 5′-GCA
CAC AGG ACC CAA AGG AGT AAT-3′ and 5′-ACA
CAA ACC CAT ACC TAG GCC CAA-3′), cone transducin
γ (Gngt2; 5′-GGA AGT GAA GAA CCC ACG TGA TCT
GA-3′ and 5′-AGC ACA CAA GTG CCT TTC TCC TTG-3′),
and hypoxanthine-guanine phosphoribosyltransferase (Hprt;
5′-CAG GCC AGA CTT TGT TGG AT-3′ and 5′- GGA CGC
AGC AAC TGA CAT T-3′). Before beginning, the primer
concentrations were optimized for each forward and reverse
primer. The qPCR reaction efficiencies for each pair were
confirmed to be within a range of 90–110%. Reactions
were prepared in technical triplicate using Brilliant SYBR
Green QPCR Master Mix (Agilent Technologies), including
reference dye, and 5 ng of each cDNA with 100 nM of each
forward and reverse primer. Reactions were incubated at
95 °C for 10 min and then cycled at 95 °C for 30 s, 55 °C for
60 s, and 72 °C for 60 s using a Stratagene (San Diego, CA)
Mx3000P real-time PCR system. A melting curve analysis
was added at the end to verify a single product from each
reaction, and the fluorescence was recorded during every
PCR cycle at the annealing step (55 °C) and the extension
step (72 °C). Finally, select PCR products were also verified
by size on agarose gels to ensure single band amplifications.
The final relative quantities of Pdc and Gngt2 expression
were determined after normalization to Hprt by the MxPro™
QPCR software version 3.00 (Stratagene). In addition, three
reference P0 samples were run in triplicate on every plate
so that interplate variations could be controlled. As a result,
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the data presented are also normalized to the P0 expression
levels.
RESULTS
Expression of phosducin in the developing mouse retina:
Phosducin (Pdc) expression is known to be specific to
photoreceptors in the retina, with expression found in rods
and cones [24,26]. Previous studies have shown phosducin
expression primarily in the early postnatal and adult retina
[27,34,35], but the expression of phosducin during embryogenesis has not been explored. Using a well-characterized
sheep antibody against phosducin [28,36,37], we identified
phosducin expression in sections of embryonic mouse retina
(Figure 1). This prompted us to perform a developmental
series of phosducin expression, covering the earliest stages of
mouse retinogenesis (E10.5) until after the maturation of rod
photoreceptors (P21, Figure 1I). No phosducin protein expression was detectable at E10.5 or E11.5 (Figure 1A,B). Starting
at E12.5, a small number of cells expressing phosducin
protein were present in the central retina (arrows in Figure
1C). Most reactive cells were present in the outer neuroblastic
layer (Figure 1D). This location is consistent with the position of the future outer nuclear layer, where differentiated
photoreceptors will reside. Given the ventricular location of
these phosducin-positive cells and the reported expression
specificity of phosducin [24,26], the labeled cells likely represent photoreceptors that have either fully or nearly completed
migration into their mature location within the neural retina.
As development proceeded, a rapid increase in the
number of phosducin-expressing cells occurred between
E12.3 and E13.5 (compare Figure 1C,D). As might be
expected from the central to peripheral gradient of retinal
differentiation [38], no phosducin-positive cells were
found in the distal retina at this age. From E13.5 to E15.5, a
gradual increase in the number of phosducin-reactive cells
was observed, with the further progression of stained cells
toward the distal retina. By E17.5, the number of phosducinpositive cells increased, and this trend continued through
the last stage tested, P21 (Figure 1F–I). To demonstrate that
the staining observed in these images accurately represents
the expression of phosducin protein, retinal sections from
a phosducin knockout mouse line [28] were processed and
reacted with anti-phosducin antibody. No reactivity was
observed anywhere within the phosducin-knockout retinas
at either E13.5 (Figure 2A) or P0 (Figure 2B), demonstrating
that the antibody showed no cross-reactivity in the retina at
embryonic or neonatal ages. For positive controls, phosducinknockout retinas and similarly aged controls were colabeled
with anti-phosducin and either anti-Otx2 at E13.5 or anti-cone
1457
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Figure 1. Developmental expression of phosducin protein in the embryonic and postnatal retina. Immunohistochemical staining was
performed on coronal sections starting at (A) E10.5 (before cone birth) through (I) P21. Anti-phosducin antibody labeled photoreceptors
starting at E12.5 (arrows in C) and continued through all time points tested. Arrowhead indicates the RPE. Scale bars = 100 µm.

transducin γ at P0. Expression of Otx2 (Figure 2A) and cone
transducin γ (Figure 2B) was observed in the control and
phosducin-knockout retinas, whereas phosducin expression
was lacking in the phosducin-knockout retinal sections.
Colocalization of phosducin and photoreceptor markers:
Examination of the coexpression of phosducin with a

known photoreceptor marker, orthodenticle homeobox 2
protein (Otx2), and a known cone-specific marker, retinoid
X receptor gamma (Rxrγ), was performed to determine the
cellular specificity of phosducin labeling in the embryonic
retina. Otx2 is important for cell fate determination of
photoreceptors and is expressed in photoreceptors and the
1458
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Figure 2. Comparison of PdcKO and control retinas. Immunofluorescence was performed on coronal sections of control and phosducin
knockout (PdcKO) mice at ages E13.5 (A) using anti-Pdc and anti-Otx2 antibodies and P0 (B) using anti-Pdc and anti-cone transducin γ
(Gngt2) antibodies. Pdc expression is seen in the control retinas and is absent in the PdcKO retinas, whereas Otx2 and Gngt2 are expressed
in the control and PdcKO retinas. Scale bars = 100 µm.

RPE until P6 [15]. Expression of Otx2 is seen in migrating
and post-migratory developing photoreceptors. We used
immunof luorescence to determine whether phosducin
and Otx2 are expressed in the same cells. Both proteins
localized to the ventricular surface with a large amount of

colocalization (Figure 3A). Phosducin-positive cells almost
always expressed Otx2; however, not all Otx2-positive cells
expressed phosducin. Otx2 was expressed prominently in
migrating (arrows in Figure 3A) photoreceptor precursors and
post-migratory photoreceptor cells. Thus, these expression
1459
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Figure 3. Colocalization of phosducin with known photoreceptor markers in the embryonic retina. A: Fluorescent imaging of coronal sections
of mouse retinas at E15.5 shows the colocalization of phosducin and Otx2, a photoreceptor marker, along the ventricular surface. Otx2 shows
RPE labeling (arrowheads) in addition to photoreceptor labeling. Otx2-positive, Pdc-negative migrating cells are also seen interior to the
ventricular surface (arrows). B: Immunofluorescent imaging of the retinal sections at E17.5 for phosducin and the cone marker, Rxrγ, shows
consistent colocalization along the ventricular surface of the retina. Scale bars = 50 µm.

patterns supported the supposition that phosducin labels postmigratory photoreceptors during embryonic ages.
Rxrγ is involved in the formation of the S-opsin gradient
of cone photoreceptors and is expressed in the embryonic
neural retina in postmitotic cones and retinal ganglion cells
with peak expression at E17.5 [20,39]. To examine the cellular
specificity of phosducin expression in developing cones, we
performed immunofluorescence with anti-phosducin and
anti-Rxrγ antibodies in E17.5 retinal sections. Both proteins
were expressed along the ventricular border of the retina
and colocalized (Figure 3B), suggesting that the majority of
phosducin-labeled cells in the embryonic retina, up to and
including E17.5, were cones.
Expression of cone transducin γ in the developing mouse
retina: Because phosducin is known to interact with transducin βγ and cone transducin γ is expressed embryonically
[21], we sought to determine the earliest age at which cone

transducin γ could be detected. Similar to the results seen
for phosducin expression, cone transducin γ was expressed
in the outer neuroblastic layer of the embryonic mouse
retina (Figure 4). Cone transducin γ protein could not be
detected through E12.5 (Figure 4A–C) but was detected
at E13.5 (Figure 4D). As with phosducin expression, cone
transducin γ-immunoreactive cells were observed only along
the ventricular edge of the retina. The expression timing and
limited expression domain suggested that cone transducin γ
may be expressed in differentiated cones only once they have
fully migrated into position, similar to phosducin. Expression
continued to expand from the central retina into the periphery
over the course of embryonic retinal development (Figure
4D–F), similar to the pattern seen with phosducin expression
(Figure 1). Unlike the expression pattern of phosducin, the
cone transducin γ-reactive cell numbers appeared to remain
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Figure 4. Developmental expression of cone transducin γ protein in the embryonic and postnatal retina. Immunohistochemical staining was
performed on coronal sections starting at (A) E10.5 (before cone birth) through (I) P21. Beginning at E13.5, cone transducin γ expression
is observed in cells along the ventricular surface (arrows in D), and this expression continues through all ages tested. Scale bars = 100 µm.

constant from E17.5 to P21 (Figure 4F–I), consistent with the
findings that 95% of cones are born by the day of birth [2,3].
Colocalization of phosducin and cone transducin γ protein
expression: Given the similar embryonic localization patterns
seen between phosducin and cone transducin γ, we used
immunofluorescence to determine whether these two proteins

colocalize in retinal cells. Examination of the expression of
both proteins from E13.5 to P8 (Figure 5A–E) showed they
were distributed widely across the retina along the central to
peripheral axis but were restricted to the ventricular layer.
Prominent colocalization of phosducin and cone transducin
γ was seen in coronal eye sections at all ages examined.
1461
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Using E13.5–P0 retinal sections, we quantified the amount
of coexpression by determining the percentage of cells that
were labeled with phosducin only, cone transducin γ only,
and those colabeled with phosducin and cone transducin γ.
At E13.5, 97% (±0.4%; SD) of the labeled cells in the retina
were colabeled. The percentage of colabeled cells dropped at
E15.5 and E17.5 to 88% (±1.1%; SD) and 87% (±2.4%; SD),
respectively, and by P0, the percentage of colabeled cells was
79% (±6.2%; SD; Figure 5F). This quantification of colocalization suggests that most phosducin-labeled cells are cones
at most embryonic ages, although rod histogenesis has begun
by this time [2,3].
Phosducin and cone transducin γ mRNA expression levels
show different dynamics: After early detection of phosducin
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and cone transducin γ expression in the developing mouse
retina with immunohistochemistry (E12.5; Figure 1C and
E13.5; Figure 4D), we sought to explore phosducin and cone
transducin γ gene expression. We analyzed mRNA expression
levels for phosducin (Pdc) and cone transducin γ (Gngt2) by
qPCR, using gene-specific primer sets. Samples were tested
from littermates used for the immunolocalization presented
above for consistency. A minimum of three biologic replicates
were analyzed and averaged for each age. Pdc expression
above the threshold was detected at E10.5 and E11.5, but these
levels were only 0.4% and 0.2% that of P0 levels, respectively
(Figure 6A). The extremely low expression levels and relative
decrease from E10.5 to E11.5 suggest that these values may
reflect the sporadic phosducin-positive protein staining seen

Figure 5. Colocalization of phosducin and cone transducin γ expression in the retina. Fluorescent imaging of coronal sections of mouse
retina from E13.5-P8 (A–E) was performed using anti-phosducin and anti-cone transducin γ antibodies. Both markers localized almost
exclusively to the ventricular surface at all ages tested. Scale bars = 50 µm. Quantification of the colabeled cell for ages E13.5–P0 (F) shows
a high percentage of colabeled cells (97% ±0.4%; SD) at E13.5 that progressively decreased with age (E15.5 was 88% ±1.1%; E17.5 was 87%
± 2.3%; P0 was 79% ±6.2%). Phosducin-only cells comprised 2.4% ±1.1% at E13.5, 11.3% ±1.3%, at E15.5, 12.3% ±2.2% at E17.5, and 20%
±6.6% at P0. Cone transducin γ–only cells constituted 0.8% ±0.7% at E13.5, 1% ±0.04% at E15.5, 1% ±0.4% at E17.5, and 1.2% ±0.7% at P0.
The blue bars indicate cells that are colabeled, the phosducin-only cells are shown in red, the cone transducin γ–only cells appear in green,
and the error bars represent standard deviations.
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Figure 6. mRNA expression across developmental ages measured with qPCR. A: Pdc expression above the threshold was detected with
qPCR at E10.5 and E11.5 but at extremely low levels. The relative Pdc expression levels increase at E12.5, which is consistent with protein
expression (see Figure 1). Expression increases gradually through P0, and then at P8, there is a dramatic increase in the Pdc mRNA levels.
B: Expression of Gngt2 mRNA is detected with qPCR at E10.5 and E11.5, but similar to phosducin, at low levels. A steady increase in Gngt2
expression occurs from E12.5 to P0. The Gngt2 levels at P8 decrease slightly relative to the P0 values. All numbers are expressed relative
to P0 and normalized to the Hprt levels in each sample and graphed on a log scale. At each age, three independent samples were collected,
and each of these samples was run in triplicate as technical replicates. Red lines indicate the average for that age group; black circles are
individual samples at each age group.

at E12.5, and that decreases between E10.5 and E11.5 could
represent stochastic variations in small numbers. No values
above the threshold were detected in samples from either the
E13.5 or P0 phosducin-knockout animals, suggesting that
other cellular RNAs do not contribute a background signal
and that these extremely low levels of phosducin expression
at E10.5 and E11.5 may represent real expression.

roughly one-third those of P0, the levels at P8 were more than
nine-fold greater than the P0 levels. This large increase in
postnatal phosducin levels is consistent with the increase seen
in phosducin protein expression and could reflect the fact
that rod photoreceptors are primarily formed during postnatal
stages of mouse development [2,38] and rods represent about
97% of the photoreceptors in the mouse retina [2,40].

The relative Pdc expression levels increased dramatically
at E12.5, with levels six-fold higher than at E11.5 and approximately 1.3% those of P0 samples (Figure 6A). Given that the
phosducin protein is first detected at this stage, this would
seem to be a minimum age at which Pdc expression can reliably be demonstrated, but earlier expression is certainly a
distinct possibility. Dramatic increases in Pdc mRNA levels
were observed between E13.5 (3.7% of P0 levels) and E15.5
(19.7% of P0 levels). Although the E17.5 levels for Pdc were

As with Pdc gene activation, expression of Gngt2 mRNA
was detected at E10.5 with qPCR, with levels at 1.4% of those
values at P0 (Figure 6B). A similar decrease was observed
for Pdc and Gngt2 from E10.5 to E11.5, with levels jumping
up 2.6-fold by E12.5. A steady increase in Gngt2 expression
occurred from E12.5 to P0. However, unlike the situation with
Pdc in which a large increase in mRNA expression occurred
between P0 and P8, the relative Gngt2 levels at P8 decreased
to 61.5% of those seen at P0. This decrease potentially reflects
1463
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the overall dilution of cone photoreceptor cell contribution
to the total RNA pool with the rapid growth of the retina
during the postnatal time period and the paucity of new cone
histogenesis that takes place postnatally.
DISCUSSION
Embryonic photoreceptor-specific expression for visual
transduction proteins: We present evidence that proteins
important for phototransduction are expressed early in
embryonic photoreceptors. We show the onset of phosducin
protein expression at E12.5, which precedes earlier reports by
nearly 2 weeks (E12.5 versus P5 [27,35]), and cone transducin
γ protein expression at E13.5, preceding the earliest reported
detection by 2 days [21]. Expression of both proteins was
nearly 3 weeks before the onset of M-opsin protein expression
at P14 and nearly 1 week before S-opsin protein expression
at P0 [5,9].
We infer that the embryonic expression of phosducin and
cone transducin γ is labeling cone photoreceptors. Several
lines of evidence support this inference. First, in the postnatal
retina, cone transducin γ is specific for cones, and phosducin
is specific for photoreceptors [24,41]. Second, cone transducin
γ- and phosducin-positive cells reside along the ventricular
border, the location of photoreceptors. Additionally, immunofluorescence showed phosducin and cone transducin γ to be
coexpressed in cells. Given the regionalized expression and
colocalization of these proteins, these findings suggest that
cone transducin γ and phosducin are expressed in photoreceptors that have migrated into their adult location, similar to the
expression pattern seen for early photoreceptor markers, Crx
[12,42] and Trβ2 [11,18]. Third, colocalization of phosducin
with Otx2 and Rxrγ, known markers for photoreceptors and
cones, respectively, suggests cone-specific labeling of phosducin at embryonic ages. Quantification of colocalization
data suggests that, at E13.5, virtually all of phosducin-labeled
cells are cones, and by E17.5, most labeled cells (87%) are still
cones, as they are phosducin- and cone transducin γ–positive.
Rapid increases in phosducin, but not cone transducin γ, in
the postnatal retina: From P0 to P8, we observed a nine-fold
increase in Pdc mRNA expression with qPCR. This increase
likely reflects the massive production of rod photoreceptors
that occurs during early postnatal development, such that
50% of all retinal cells and 97% of all mouse photoreceptors
are rods [2,40]. The possibility also exists that, in addition to
a dramatic increase in rod cell numbers during this period,
the expression levels of phosducin within each photoreceptor
could be increasing. With this caveat in mind, however, the
magnitude of change for phosducin expression was consistent
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with the increase in rod cell number during early postnatal
retinal development [3].
Potential functions for visual transduction proteins in the
embryonic retina: Surprisingly, the temporal pattern of
phosducin and cone transducin γ was coincident with the
expression of early cone-determining transcription factors,
suggesting that photoreceptor precursor cells are fully
committed to a cone differentiation pattern at these early
ages. Since the phototransduction process is weeks removed
from this expression, these visual transduction factors likely
play other functional roles in the embryonic photoreceptor
cell. We observed an absence of other visual transduction
proteins (mouse cone arrestin, cone phosphodiesterase and
S-cone opsin) in the mouse retina at E15.5. Although visual
transduction proteins have been found embryonically in the
primate retina [43,44], this expression is at a stage of development that matches the postnatal period in rodents, suggesting
that cone transducin γ and phosducin may have specific functions in the embryonic retina unrelated to their roles in visual
transduction.
As a result, we sought clues in the literature to identify
potential activity of cone transducin γ and phosducin in the
embryonic mouse retina, if any. Previous studies on phosducin show that it can interact with Crx in cultured cells,
where phosducin acts to inhibit Crx-mediated transcription
at the interphotoreceptor retinoid-binding protein (IRBP)
promoter [45]. In addition, phosducin possesses a transcriptional activation domain at the C-terminal end [46], although
this would appear to conflict with the reported repression
of Crx transcriptional activity [45]. Previous studies have
yielded conflicting information regarding the localization of
phosducin. Whereas Zhu et al. [45] demonstrated that phosducin colocalized to the nucleus when coexpressed with Crx
in Cos7 cells and in the adult bovine retina (where phosducin
shows nuclear and cytoplasmic localization), the same group
[46] and others [47,48] found phosducin to be cytoplasmic. If
phosducin localized to the nucleus, this finding would suggest
a possible role in transcription; however, the cytoplasmic
localization seen in our study would suggest that perhaps
there is an additional function for embryonic phosducin
beyond any transcriptional activities.
Another possible function for embryonic phosducin
expression is that phosducin may interact with cone transducin βγ as phosducin does postnatally [49]. This possibility
would lead to the obvious question regarding the potential
function for G protein βγ at embryonic ages. Although the
transducin βγ complex is known to function only in phototransduction, the function of the transducin βγ complex
during embryonic stages has not been explored to our
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knowledge. Given the large number of G protein-coupled
receptors (GPCRs) and their expression in multiple tissues
and cell types, it is conceivable that the transducin βγ
complex has additional functions during embryonic retinal
development that have yet to be fully understood or explored.
Some potential GPCR signaling pathways involved in retinal
function include dopamine signaling [50,51], hedgehog (Hh)
signaling [52,53], and Wnt signaling [54], along with others
[55,56]. Wnt signaling in the retina appears to function
primarily in the RPE at embryonic ages [54], and therefore is
unlikely to involve phosducin and cone transducin γ activity
in photoreceptor cell differentiation. Dopamine signaling
appears to occur at later embryonic and postnatal stages
than seen for the earliest phosducin and cone transducin γ
expression [51]. Hh signaling plays a significant role in retinal
progenitor cell proliferation [57], and factors induced by Hh
signaling (e.g., Gli1) overlap spatially and temporally with
the expression for phosducin shown above [58]. However,
functional manipulation of Hh signaling [58-60] suggests that
it either antagonizes cone photoreceptor specification or has a
transient role in cone differentiation. Therefore, further work
is necessary to elucidate the early functions for phosducin and
cone transducin γ in the developing retina and their potential
roles in photoreceptor cell differentiation.
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